Skip to Content



View full screen / Print PDF » Download PDF ⇩

PDF Transcript

Amsidine 50 mg/ml Injection
Amsacrine Concentrate for Infusion
Keep this leaflet. You may need to read it again.
If you have any further questions, ask your doctor or pharmacist.
If any of the side effects become serious, or if you notice any side effects not listed in this leaflet, please
tell your doctor or pharmacist.

In this leaflet:
1. What Amsidine Injection is and what it is used for
2. Before you are given Amsidine Injection
3. How Amsidine Injection is given
4. Possible side effects
5. How to store Amsidine Injection
6. Further information
Amsidine Injection is one of a group of medicines called antineoplastic (anticancer) agents.
It is used to treat acute leukaemia, a form of cancer of the white cells in your blood.

You should not be given Amsidine Injection if:
• You know that you are allergic to amsacrine or to any of the other ingredients (see section 6 of this
• You are already receiving other treatments for cancer, including radiation, which have affected your
bone marrow or you have received treatments in the past (your doctor will advise you)
• You are under 12 years old.
• You are in the first 3 months of pregnancy.
• You are breast feeding
Speak to your doctor before you are given this injection if any of these apply to you.
Before you are given Amsidine Injection, your doctor will take special care if any of the following
situations apply to you. Make sure your doctor is aware of these situations if it is not already
• You have ever had a kidney or liver disease
• You have any problem with your heart
• You have a problem with your nervous system or brain
• You have been told that the potassium level in your blood is too low.
Speak to your doctor before you are given this injection if any of these apply to you.
Taking or receiving other medicines:

AMSA UK WS001 PIL 28Jan2015


Tell your doctor before you are given this medicine if you are taking or have recently taken any other
medicines, including medicines obtained without a prescription.
Some medicines can interact with Amsidine Injection which can significantly alter their effects. These
drugs include:
• Vaccines such as Common Influenza and Pneumonia Vaccine.
• Other medicines or radiation used in the treatment of cancer.
If you are already taking one of these medicines, speak to you doctor before you receive Amsidine
Pregnancy and breast-feeding
Tell your doctor before you are given this medicine if you are or think you may be pregnant or are
planning to become pregnant, or are breast-feeding.
This medicine should not be given during pregnancy especially during the first three months of
pregnancy. You must speak to your doctor about the possible effects this medicine might have on your
baby before you are given this medicine.
You should not take this medicine if you are breast-feeding. You should avoid becoming pregnant for at
least three months after your treatment with Amsidine has stopped.
Amsidine affects sperm. You should avoid fathering a child for at least six months after your treatment
has stopped.
Driving and using machines
Amsidine Injection should not affect your ability to drive or use machinery. However, if you experience
any side effects after having the injection ask your doctor’s advice if you can drive.

You will be in hospital when you are given Amsidine Injection.
A dose of Amsidine will be dissolved in a sugar solution and slowly injected into a vein over 60 - 90
minutes. This is known as an infusion and will be performed under the supervision of a doctor
experienced in cancer treatment.
The dose will be calculated by your doctor according to your age and the surface area of your body
(normally 90mg per square metre).
You will be given one infusion a day for 5 - 8 days.

Blood monitoring should be done for all patients treated with Amsidine. Close monitoring of the blood
levels should be done including the complete blood counts,
urine tests and in some cases blood Amsidine monitoring along with liver and kidney function tests to
detect any problems.

Following this initial dosing period, further doses will be given every 3 – 4 weeks, depending on the
number of your blood cells. This second course of treatment will generally be one third of the original
dose and will either be given all on one day or divided up over 3 days.
If Amsidine Injection decreases the number of your blood cells too much, it may be necessary for your
doctor to give you a blood transfusion.

AMSA UK WS001 PIL 28Jan2015


If you have any further questions on the use of this product, ask your doctor.
If you think you have been given more Amsidine Injection than you should have
As the injection will be administered under the supervision of a doctor, it is unlikely that you will be given
more than is necessary. However, if you have any concerns about the dose of your medicine discuss
them with your doctor.

Like all medicines Amsidine Injection can sometimes cause side-effects, although not everybody gets
All medicines can cause allergic reactions although serious allergic reactions are rare. Any
sudden wheeziness, difficulty in breathing, swelling of the eyelids, face or lips, rash or itching
(especially affecting your whole body) should be reported to a doctor immediately.
Amsidine can make you more likely to catch infections. If you think you have an infection, a
sore throat, fever, chills, or achiness during treatment you should tell your doctor immediately.
The side-effects reported with Amsidine are as follows:
Tell your doctor straight away if you notice any of the following side effects:
Very Common – (affects more than 1 in 10 people)
• Feeling sick (nausea) or vomiting
• Loose stools
• Abdominal pain
• Ulcers in the mouth
• On investigation, if there is an increase in liver enzymes
• Inflammation of the veins at the site of the injection

Common – (Affects more than 1 in 10 people)
• Increase or decrease in blood cell count on investigation
• Increased risk of bruising or bleeding.
• Reduced potassium levels in the blood
• Emotional instability
• Epilepsy (Fits)
• Heart Problems (racing heart, heart failure)
• Breathlessness
• Yellowing of the skin or whites of the eyes caused by liver or blood problems
• Hair Loss
• Skin rash
• Raised itchy red welts on the surface of the skin
• Blood in the urine
• Fever
• Skin Irritation, black discolouration and redness and swelling at the injection site
Rare – (affects less than 1 in 1,000 people)
• Reduction in red blood cells which can make the skin pale and cause weakness or breathlessness
• Increase or decrease in weight
• Confusion
• Headache, dizziness
• Reduced sense of touch
• Difficulty or pain while passing urine

AMSA UK WS001 PIL 28Jan2015


• On urine examination, high levels of proteins may be seen
• On blood examination, high levels of some enzymes may be seen
Not Known – (cannot be estimated from the available data)
• Bone marrow failure
• Cardiac arrest
Painful swelling of the joints (Gout) may be seen in some cases due to increase in uric acid levels in the
If you develop sign of serious allergic reaction, you must contact you doctor immediately.
If you get any of these side effects, or if you notice any side effects not listed in this leaflet, please tell
your doctor at once.
Certain other unwanted effects can only be detected by your doctor, these include blood disorders, and
changes in liver and kidney function
Although the above list of possible side effects appears daunting, acute leukaemia is a serious disease
which requires aggressive treatment.


The storage of Amsidine Injection will not be your responsibility.
However, keep in a dry place and do not store above 25°C. Keep in the outer carton in order to protect
from light.
Keep out of the reach and sight of children.
Do not use Amsidine Injection after the expiry date which is stated on the vial and outer carton.
If only part used, discard the remaining solution.


What Amsidine Injection contains
The active substance is amsacrine.
The other ingredients are N,N, Dimethylacetamide, L-lactic acid and water for injection.
What Amsidine Injection looks like and contents of pack
Amsidine Injection comes as two types of small glass bottles. One small sealed clear glass bottle (vial)
contains the active ingredient, which is 75mg of amsacrine.
It also contains an inactive ingredient, which is N,N, dimethylacetamide in 1.5ml as a clear bright
orange/red liquid.
A second glass bottle (vial) contains 13.5ml of a solution of L-lactic acid in Water for Injection.
Marketing authorization holder
NordMedica A/S
Jægersborg Allé 164, DK.2820 Gentofte, Denmark.

AMSA UK WS001 PIL 28Jan2015


Eurocept BV, Trapgans 5, NL-1244 RL Ankeveen, The Netherlands.
Amsidine 50mg/ml Injection is a trade mark.
This leaflet was last approved in December 2014.

AMSA UK WS001 PIL 28Jan2015


Expand Transcript

Source: Medicines and Healthcare Products Regulatory Agency

Disclaimer: Every effort has been made to ensure that the information provided here is accurate, up-to-date and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. This information has been compiled for use by healthcare practitioners and consumers in the United States. The absence of a warning for a given drug or combination thereof in no way should be construed to indicate that the drug or combination is safe, effective or appropriate for any given patient. If you have questions about the substances you are taking, check with your doctor, nurse or pharmacist.